SlideShare ist ein Scribd-Unternehmen logo
1 von 61
An Overview of the Pharmaceutical Industry Syed Adeel Ahmed Business Development Manager Atco Laboratories Limited May 21, 2010
Global View of the Industry May 21, 2010
Global Company Sales May 21, 2010
Global Company Sales May 21, 2010
Global Company Sales May 21, 2010
The Past, Connecting Future ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],May 21, 2010
Growth Trend of the Global Industry May 21, 2010 Growth trend
Top products (by sales 06) May 21, 2010
Top products (by sales 06) May 21, 2010
Top products (by sales 06) May 21, 2010
Overview of Industry in Pakistan May 21, 2010
Macro Analysis of Pakistan Pharma market  (last 5 fiscal years) May 21, 2010 Rs. Million IMS Health
Local Company Sales May 21, 2010 Fiscal year 07-08
The Players May 21, 2010 Fiscal year 07-08
The Players May 21, 2010 Fiscal year 07-08 Total companies:  681 Share of top-50:  84%
Therapeutics May 21, 2010 Fiscal year 07-08
Disease Profile of Pakistan May 21, 2010
May 21, 2010 ,[object Object],In Pakistan….
May 21, 2010 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Major Contributor of CVD
May 21, 2010 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Major Contributor of CVD
May 21, 2010 Diabetes, a Growing Global Crisis Adapted from Zimmet P et al.  Diabet Med . 2003;20:693-702. 30 million people in 1985 189 million people in 2003 324 million projected for 2025 72% increase Diabetes mellitus is a very serious public health problem which prevalence is increasing rapidly 25.0 39.7 59% 10.4 19.7 88% 38.2 44.2 16% 1.1 1.7 59% 13.6 26.9 98% 81.8 156.1 91% 18.2 35.9 97%
May 21, 2010 Rank Country 1995    Country 2025 (million)  (million) 1 India 19.4   India 57.2 2 China 16   China 37.6 3 U.S. 13.9   U.S. 21.9 4 Russian Federation 8.9   Pakistan 14.5 5 Japan 6.3   Indonesia 12.4 6 Brazil 4.9   Russian Federation 12.2 7 Indonesia 4.5   Mexico 11.7 8 Pakistan 4.3   Brazil 11.6 9 Mexico 3.8   Egypt 8.8 14 Ukraine 3.6   Japan 8.5 All other countries 49.7 103.6 Total 135.3 300.0 Prevalence of Diabetes in World
Hepatitis C ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],May 21, 2010
Hepatitis C ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],May 21, 2010
Top Products (by sales 07-08) May 21, 2010
Top Products (by sales 07-08) May 21, 2010
Top Products (by sales 07-08) May 21, 2010
Pharmaceutical Marketing Mix May 21, 2010 Product Place Promotion Price P P P P
The Product ,[object Object],[object Object],May 21, 2010
The Product ,[object Object],[object Object],[object Object],May 21, 2010
The Product ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],May 21, 2010
The Price ,[object Object],[object Object],May 21, 2010
The Price ,[object Object],[object Object],May 21, 2010
The Price ,[object Object],[object Object],[object Object],[object Object],[object Object],May 21, 2010
The Price ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],May 21, 2010
Promotion Pharmaceutical Marketing May 21, 2010
May 21, 2010 HOME Patients visits a Dr  Doctor Rx  Distributor Drug Factory Drug Buying Behavior Reps  visits a Dr  Dr write prescription Buying Process Pharmacy
Pharmaceutical Marketing ,[object Object],[object Object],[object Object],May 21, 2010
Pharmaceutical Marketing ,[object Object],[object Object],[object Object],May 21, 2010
Direct and indirect marketing to health care providers ,[object Object],[object Object],[object Object],May 21, 2010
Direct and indirect marketing to health care providers ,[object Object],[object Object],May 21, 2010
Direct and indirect marketing to health care providers ,[object Object],[object Object],May 21, 2010
Direct and indirect marketing to health care providers ,[object Object],[object Object],May 21, 2010
Direct and indirect marketing to health care providers ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],May 21, 2010
Direct physician contact with pharma sales reps ,[object Object],[object Object],May 21, 2010
Direct physician contact with pharma sales reps ,[object Object],May 21, 2010
Direct physician contact with pharma sales reps ,[object Object],[object Object],May 21, 2010
Physician Targeting ,[object Object],May 21, 2010
Physician Targeting ,[object Object],May 21, 2010
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Physician Targeting May 21, 2010
Opinion Leader Influence Mapping ,[object Object],May 21, 2010
Opinion Leader Influence Mapping ,[object Object],May 21, 2010
Sales force size and structure ,[object Object],[object Object],May 21, 2010
[object Object],Sales force size and structure May 21, 2010
Place (of distribution) ,[object Object],[object Object],May 21, 2010
Place (of distribution) ,[object Object],[object Object],[object Object],May 21, 2010
Regulations on Pharmaceutical Industry May 21, 2010
What is regulated? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],May 21, 2010
International Marketing (Exports) of Pharmaceuticals from Pakistan May 21, 2010
Exports ,[object Object],May 21, 2010
Thank you …  May 21, 2010

Weitere ähnliche Inhalte

Was ist angesagt?

Glaxo-smith-kline-presentation.
 Glaxo-smith-kline-presentation. Glaxo-smith-kline-presentation.
Glaxo-smith-kline-presentation.
Ishdeep Singh
 
Indian Pharmaceutical Industry
Indian Pharmaceutical IndustryIndian Pharmaceutical Industry
Indian Pharmaceutical Industry
Chandni Sahgal
 

Was ist angesagt? (20)

Trends & Opportunities for Indian Pharma
Trends & Opportunities for Indian PharmaTrends & Opportunities for Indian Pharma
Trends & Opportunities for Indian Pharma
 
Pharma Sector of INDIA
Pharma Sector of INDIAPharma Sector of INDIA
Pharma Sector of INDIA
 
Competitive Analysis of Abbott Laboratories
Competitive Analysis of Abbott LaboratoriesCompetitive Analysis of Abbott Laboratories
Competitive Analysis of Abbott Laboratories
 
Scope and opportunities of pharmacy
Scope and opportunities of pharmacyScope and opportunities of pharmacy
Scope and opportunities of pharmacy
 
PRESENT SCENARIO OF INDIAN PHARMACEUTICAL INDUSTRY IN VIEW OF GLOBAL ...
PRESENT  SCENARIO  OF  INDIAN  PHARMACEUTICAL  INDUSTRY IN  VIEW  OF  GLOBAL ...PRESENT  SCENARIO  OF  INDIAN  PHARMACEUTICAL  INDUSTRY IN  VIEW  OF  GLOBAL ...
PRESENT SCENARIO OF INDIAN PHARMACEUTICAL INDUSTRY IN VIEW OF GLOBAL ...
 
Indian pharmaceutical industry
Indian pharmaceutical industry Indian pharmaceutical industry
Indian pharmaceutical industry
 
Indian Pharma Industry
Indian Pharma IndustryIndian Pharma Industry
Indian Pharma Industry
 
Glaxo-smith-kline-presentation.
 Glaxo-smith-kline-presentation. Glaxo-smith-kline-presentation.
Glaxo-smith-kline-presentation.
 
“SWOT ANALYSIS OF NEW PHARMACEUTICAL COMPANY”
“SWOT ANALYSIS OF NEW PHARMACEUTICAL COMPANY”“SWOT ANALYSIS OF NEW PHARMACEUTICAL COMPANY”
“SWOT ANALYSIS OF NEW PHARMACEUTICAL COMPANY”
 
Indian Pharmaceutical Industry
Indian Pharmaceutical IndustryIndian Pharmaceutical Industry
Indian Pharmaceutical Industry
 
Pharmaceutical Marketing
Pharmaceutical MarketingPharmaceutical Marketing
Pharmaceutical Marketing
 
Marketing of a pharma (Basic)
Marketing of a pharma (Basic)Marketing of a pharma (Basic)
Marketing of a pharma (Basic)
 
Marketing Plan
Marketing PlanMarketing Plan
Marketing Plan
 
Kenya Pharma Market Analysis
Kenya Pharma Market AnalysisKenya Pharma Market Analysis
Kenya Pharma Market Analysis
 
Zafa pharma pest analysis
Zafa pharma pest analysisZafa pharma pest analysis
Zafa pharma pest analysis
 
Scope of pharmacy ppt
Scope of pharmacy pptScope of pharmacy ppt
Scope of pharmacy ppt
 
Forensic pharmacy (pharmaceutical jurisprudence)
Forensic pharmacy (pharmaceutical jurisprudence)Forensic pharmacy (pharmaceutical jurisprudence)
Forensic pharmacy (pharmaceutical jurisprudence)
 
Status of pharmaceutical industry in india
Status of pharmaceutical industry in indiaStatus of pharmaceutical industry in india
Status of pharmaceutical industry in india
 
Pharmaceutical Industry
Pharmaceutical IndustryPharmaceutical Industry
Pharmaceutical Industry
 
Pharmaceutical industry in india
Pharmaceutical industry in indiaPharmaceutical industry in india
Pharmaceutical industry in india
 

Ähnlich wie Pakistan Pharma Overview

Newtech advant-business-plan9
Newtech advant-business-plan9Newtech advant-business-plan9
Newtech advant-business-plan9
Yousaf Khan
 
Pharmaceutical Marketing Management
Pharmaceutical Marketing ManagementPharmaceutical Marketing Management
Pharmaceutical Marketing Management
Sheraz Pervaiz
 
Healthcasts_Whitepaper_5_Key_Physician_Insights_Pharma_Needs_to_Know
Healthcasts_Whitepaper_5_Key_Physician_Insights_Pharma_Needs_to_KnowHealthcasts_Whitepaper_5_Key_Physician_Insights_Pharma_Needs_to_Know
Healthcasts_Whitepaper_5_Key_Physician_Insights_Pharma_Needs_to_Know
Debra Harris
 
Investigation of the accessibility and affordability of medicines in speciali...
Investigation of the accessibility and affordability of medicines in speciali...Investigation of the accessibility and affordability of medicines in speciali...
Investigation of the accessibility and affordability of medicines in speciali...
Cornelis Jan Diepeveen
 

Ähnlich wie Pakistan Pharma Overview (20)

Pharmaceutical Industry Analytics
Pharmaceutical Industry AnalyticsPharmaceutical Industry Analytics
Pharmaceutical Industry Analytics
 
Pharmaceutical Supply Chain Dynamics and Intelligence
Pharmaceutical Supply Chain Dynamics and IntelligencePharmaceutical Supply Chain Dynamics and Intelligence
Pharmaceutical Supply Chain Dynamics and Intelligence
 
Pharma marketing & policies
Pharma marketing & policiesPharma marketing & policies
Pharma marketing & policies
 
PMRG 2008 Presentation
PMRG 2008 PresentationPMRG 2008 Presentation
PMRG 2008 Presentation
 
2014 Profile: Biopharmaceutical Research Industry
2014 Profile: Biopharmaceutical Research Industry2014 Profile: Biopharmaceutical Research Industry
2014 Profile: Biopharmaceutical Research Industry
 
Newtech advant-business-plan9
Newtech advant-business-plan9Newtech advant-business-plan9
Newtech advant-business-plan9
 
Challenges of pharmaceutical industry in 2015
Challenges of pharmaceutical industry in 2015Challenges of pharmaceutical industry in 2015
Challenges of pharmaceutical industry in 2015
 
The future of pharma marketing
The future of pharma marketingThe future of pharma marketing
The future of pharma marketing
 
Prescription Medicines Costs in Context April 2021
Prescription Medicines Costs in Context April 2021Prescription Medicines Costs in Context April 2021
Prescription Medicines Costs in Context April 2021
 
Final
FinalFinal
Final
 
Read Logica’s paper on the need for convergence of healthcare and pharma
Read Logica’s paper on the need for convergence of healthcare and pharmaRead Logica’s paper on the need for convergence of healthcare and pharma
Read Logica’s paper on the need for convergence of healthcare and pharma
 
Generic drug
Generic drugGeneric drug
Generic drug
 
Tech opens a window for OTC
Tech opens a window for OTCTech opens a window for OTC
Tech opens a window for OTC
 
Ims global use_of_meds_report_2013
 Ims global use_of_meds_report_2013 Ims global use_of_meds_report_2013
Ims global use_of_meds_report_2013
 
Wiekang Biotech Investor Presentation, June 2010
Wiekang Biotech Investor Presentation, June 2010Wiekang Biotech Investor Presentation, June 2010
Wiekang Biotech Investor Presentation, June 2010
 
Pharmaceutical Marketing Management
Pharmaceutical Marketing ManagementPharmaceutical Marketing Management
Pharmaceutical Marketing Management
 
Healthcasts_Whitepaper_5_Key_Physician_Insights_Pharma_Needs_to_Know
Healthcasts_Whitepaper_5_Key_Physician_Insights_Pharma_Needs_to_KnowHealthcasts_Whitepaper_5_Key_Physician_Insights_Pharma_Needs_to_Know
Healthcasts_Whitepaper_5_Key_Physician_Insights_Pharma_Needs_to_Know
 
IMS - Global Use of Medicines 2020 by Nitesh Bhele
IMS - Global Use of Medicines 2020 by Nitesh BheleIMS - Global Use of Medicines 2020 by Nitesh Bhele
IMS - Global Use of Medicines 2020 by Nitesh Bhele
 
Investigation of the accessibility and affordability of medicines in speciali...
Investigation of the accessibility and affordability of medicines in speciali...Investigation of the accessibility and affordability of medicines in speciali...
Investigation of the accessibility and affordability of medicines in speciali...
 
Prescription Medicines Costs in Context July 2021
Prescription Medicines Costs in Context July 2021Prescription Medicines Costs in Context July 2021
Prescription Medicines Costs in Context July 2021
 

Pakistan Pharma Overview